Deep vein thrombosis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
Males have more risk than females and the risk increases with age in both sex. | Males have more risk than females and the risk increases with age in both sex. | ||
Caucasians and African Americans have a significantly higher incidence than Hispanics | |||
and Asians or Pacific Islanders | |||
DVT is much less common in the pediatric population. About 1 in 100,000 people under the age of 18 experiences deep vein thrombosis, possibly due to | DVT is much less common in the pediatric population. About 1 in 100,000 people under the age of 18 experiences deep vein thrombosis, possibly due to |
Revision as of 15:57, 29 August 2011
Editors-in-Chief: C. Michael Gibson, M.S., M.D. Associate Editor-In-Chief: Ujjwal Rastogi, MBBS [1]
Deep Vein Thrombosis Microchapters |
Diagnosis |
---|
Treatment |
Special Scenario |
Trials |
Case Studies |
Deep vein thrombosis epidemiology and demographics On the Web |
Deep vein thrombosis epidemiology and demographics in the news |
Risk calculators and risk factors for Deep vein thrombosis epidemiology and demographics |
Overview
Deep Vein Thrombosis and Pulmonary Embolism (DVT/PE) represent a major public health problem, exacting a significant human and economic toll on the Nation.
Epidemiology and Demographics
It is estimated that approximately 350,000 to 600,000 Americans each year suffer from DVT and pulmonary embolism and at least 100,000 deaths may be directly or indirectly related to these diseases[2].
Males have more risk than females and the risk increases with age in both sex.
Caucasians and African Americans have a significantly higher incidence than Hispanics and Asians or Pacific Islanders
DVT is much less common in the pediatric population. About 1 in 100,000 people under the age of 18 experiences deep vein thrombosis, possibly due to
- Children heartrate being higher than adult
- Relatively active lifestyle when compared with adults
- Fewer comorbidities (e.g. malignancy).